Rehydration Liquid
NDC Package 64578-0175-1
Package Information
Rehydration (adenosinum cyclophosphoricum, coffea cruda, glandula suprarenalis suis, hypothalamus, kali phos, nat mur, sarsaparilla, silicea, taraxacum, thyroidinum) liquids is Uses Temporary relief of increased or decreased thirst, dryness, headaches. This formulation utilizes a liquid delivery system. Marketed by Energetix Corporation, this product is identified by NDC 64578-0175.
Identification & Billing
Clinical Specifications
- ADENOSINE CYCLIC PHOSPHATE 12 [hp_X]/118.2mL
- ARABICA COFFEE BEAN 9 [hp_X]/118.2mL
- BOS TAURUS HYPOTHALAMUS 12 [hp_X]/118.2mL
- DIBASIC POTASSIUM PHOSPHATE 6 [hp_X]/118.2mL
- SARSAPARILLA 4 [hp_X]/118.2mL
- SILICON DIOXIDE 12 [hp_X]/118.2mL
- SODIUM CHLORIDE 8 [hp_X]/118.2mL
- SUS SCROFA ADRENAL GLAND 9 [hp_X]/118.2mL
- TARAXACUM OFFICINALE ROOT 4 [hp_X]/118.2mL
- THYROID, UNSPECIFIED 12 [hp_X]/118.2mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0175 - Rehydration
- 64578-0175-1 - 118.2 mL in 1 BOTTLE
- 64578-0175 - Rehydration
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0175-1 identifies a specific commercial package of 118.2 ml in 1 bottle of Rehydration, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains adenosine cyclic phosphate; arabica coffee bean; bos taurus hypothalamus; dibasic potassium phosphate; sarsaparilla; silicon dioxide; sodium chloride; sus scrofa adrenal gland; taraxacum officinale root; thyroid, unspecified as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on March 24, 2023. The current certification is valid through December 31, 2026.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578017501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.